A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: A single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model
- 1 October 2002
- journal article
- case report
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (10) , 1549-1560
- https://doi.org/10.1016/s0149-2918(02)80059-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator—controlled clinical trialClinical Therapeutics, 2001
- Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in OsteoarthritisArchives of internal medicine (1960), 2000
- CelecoxibDrugs, 2000
- Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.JAMA, 1999
- Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator-controlled clinical trialClinical Therapeutics, 1999
- Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trialObstetrics & Gynecology, 1999
- Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: A randomized, controlled trialClinical Therapeutics, 1999
- Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain modelClinical Pharmacology & Therapeutics, 1999
- RofecoxibDrugs, 1999
- RofecoxibDrugs of the Future, 1998